Accumulating evidence indicated that the IL-18 promoter genotype was correlated with the risk of PC, nasopharyngeal carcinoma (NPC), HCC and NSCLC [182,183,184,185]. This evidence concerns the gene IL18 and hepatocellular carcinoma.